Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Emadi

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Blood|September 12, 2015
Exploiting AML vulnerability: glutamine dependencyAshkan Emadi
Blood|October 19, 2013
Philadelphia chromosome positive acute B-lymphoblastic leukemia with extreme leukocytosisVishal Bhatnagar, Ashkan Emadi
Pharmaceuticals (Basel, Switzerland)|March 3, 2021
1-C Metabolism-Serine, Glycine, Folates-In Acute Myeloid LeukemiaKanwal Mahmood, Ashkan Emadi
The New England Journal of Medicine|February 3, 2007
Intoxication of a hospitalized patient with an isopropanol-based hand sanitizerAshkan Emadi, LeAnn Coberly
International Journal of Preventive Medicine|March 27, 2012
Vitamin and mineral supplements: do we really need them?Farin Kamangar, Ashkan Emadi
Archives of Iranian Medicine|November 2, 2011
Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuriaAshkan Emadi, Michael Streiff
Archives of Iranian Medicine|September 6, 2011
Diagnosis and management of venous thromboembolism: an update a decade into the new millenniumAshkan Emadi, Michael Streiff
Blood|June 13, 2009
From orbital hybridization to chemotherapeutics neutralizationNilanjan Ghosh, Ashkan Emadi
Archives of Iranian Medicine|February 4, 2016
Dr. Amir Masoud EmadiAshkan Emadi, Reza Malekzadeh
Cancer Chemotherapy and Pharmacology|March 10, 2010
Ruthenium-based chemotherapeutics: are they ready for prime time?Emmanuel S Antonarakis, Ashkan Emadi
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Blood|September 12, 2015
Exploiting AML vulnerability: glutamine dependencyAshkan Emadi
Blood|October 19, 2013
Philadelphia chromosome positive acute B-lymphoblastic leukemia with extreme leukocytosisVishal Bhatnagar, Ashkan Emadi
Pharmaceuticals (Basel, Switzerland)|March 3, 2021
1-C Metabolism-Serine, Glycine, Folates-In Acute Myeloid LeukemiaKanwal Mahmood, Ashkan Emadi
The New England Journal of Medicine|February 3, 2007
Intoxication of a hospitalized patient with an isopropanol-based hand sanitizerAshkan Emadi, LeAnn Coberly
International Journal of Preventive Medicine|March 27, 2012
Vitamin and mineral supplements: do we really need them?Farin Kamangar, Ashkan Emadi
Archives of Iranian Medicine|November 2, 2011
Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuriaAshkan Emadi, Michael Streiff
Archives of Iranian Medicine|September 6, 2011
Diagnosis and management of venous thromboembolism: an update a decade into the new millenniumAshkan Emadi, Michael Streiff
Blood|June 13, 2009
From orbital hybridization to chemotherapeutics neutralizationNilanjan Ghosh, Ashkan Emadi
Archives of Iranian Medicine|February 4, 2016
Dr. Amir Masoud EmadiAshkan Emadi, Reza Malekzadeh
Cancer Chemotherapy and Pharmacology|March 10, 2010
Ruthenium-based chemotherapeutics: are they ready for prime time?Emmanuel S Antonarakis, Ashkan Emadi
Pageof 12